Subscribe to Newsletter

Content by Roisin McGuigan:

Subspecialties Basic & Translational Research

AMD Clinical Trials

| Mark Hillen, Roisin McGuigan

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.

Subspecialties Professional Development

The Long and Winding Road to VEGF

| Roisin McGuigan

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Subspecialties Glaucoma

Wireless Drug Dosing

| Roisin McGuigan

“Smart” nanowires deliver drugs on demand using an applied electromagnetic field

Subspecialties Retina

Standardizing Stem Cell Selection

| Roisin McGuigan

Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?

Subspecialties Cornea / Ocular Surface

Minimally Invasive, Maximally Successful

| Roisin McGuigan

An updated surgical technique restores sensation to patients with corneal anesthesia

Subspecialties Retina

The Argus II: Thirty Patients with RP, Three Years Later

| Roisin McGuigan

The Argus II: Thirty Patients with RP, Three Years Later

Business & Profession Cornea / Ocular Surface

Incredible Images

| Mark Hillen, Roisin McGuigan, Michael Schubert

Tumbling Es and Philanthropy

Subspecialties Retina

A DRAMatic Result

| Roisin McGuigan

A protein involved in autophagy, DRAM2, appears to be essential for photoreceptor survival

Business & Profession Other

Strabismus Screening – Now There’s an App for That

| Roisin McGuigan

A smartphone app could simplify strabismus screening and pave the way for telemedicine

Subspecialties Retina

Images of the Posterior Segment

| Mark Hillen, Roisin McGuigan, Michael Schubert

See More. Treat More Effectively

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: